View live charts, options flow & technicals for Albemarle Corporation →
Open Dashboard
Albemarle Corporation (ALB) is a basic materials company in the specialty chemicals industry with $5.91B in trailing revenue trading at a 406.4× trailing P/E — analyst consensus: buy.
Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles; power grids and solar panels; high-performance greases; and specialty glass used in consumer appliances and electronics. The Specialties segment provides bromine and highly specialized lithium solutions for various industries, such as energy, mobility, connectivity, and health comprising fire safety compounds; bromine-based specialty chemical products, including elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and various bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications, including airbag initiators. This segment also provides organic synthesis processes in the areas of steroid chemistry and vitamins, and various life science applications, as well as intermediates for the pharmaceutical industry; technical services, including handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The Ketjen segment offers clean fuels technologies, including hydroprocessing catalysts together with isomerization and alkylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves the grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals, and medical device industries. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
Key Statistics
Market Cap
$12.95B
Revenue (TTM)
$5.91B
EPS (TTM)
$0.27
EPS (Fwd est.)
$11.30
Employees
7,800
Trailing P/E
406.41
Forward P/E
9.71
PEG Ratio
0.79
Price / Sales
2.19
Price / Book
1.61
EV / EBITDA
10.66
Beta (5Y)
1.33
Analyst Consensus
Consensus
Buy
Analyst Price Target
+56.4% upside
Target: $171.56
Annual Revenue & Net Income
RevenueNet Income
'22
$7.32B
$2.69B
'23
$9.62B
$1.57B
'24
$5.38B
$-1.18B
'25
$5.14B
$-510.00M
Earnings History
Quarter
Actual EPS
Estimate
Result
Aug 2026
$3.75
$3.24
Beat (+15.7%)
May 2026
$2.95
$1.31
Beat (+124.6%)
Feb 2026
$-0.53
$-0.49
Miss (-8.6%)
Nov 2025
$-0.19
$-0.88
Beat (+78.3%)
Next Earnings Report
Albemarle Corporation is next expected to report earnings on 04 Nov 2026.
Profitability
24.0%
27.7%
3.8%
Gross MarginOperating MarginNet Margin
Revenue Growth (YoY)
31.1%
Return on Equity
2.6%
Return on Assets
3.2%
Balance Sheet
Cash & Equivalents
$1.63B
Total Debt
$2.00B
Net Position
$370.00M (net debt)
Free Cash Flow (TTM)
$1.33B
Debt / Equity
18.98
Share Ownership
Institutions 101.8%
Insiders 0.2%
Institutional figure exceeds 100% due to short selling
Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles; power grids and solar panels; high-performance grease…
What is ALB's market cap?
Albemarle Corporation has a market capitalization of approximately $12.95B.
What is ALB's P/E ratio?
Albemarle Corporation trades at a trailing P/E ratio of 406.4x and a forward P/E of 9.7x, which is above the broad market average of ~25x.
How much revenue does ALB generate?
Albemarle Corporation generated $5.91B in trailing 12-month revenue.
What do analysts say about ALB?
The analyst consensus rating for Albemarle Corporation is buy, with a mean price target of $171.56. That implies +56.4% upside from the current price.
When does ALB report earnings?
Albemarle Corporation is next scheduled to report earnings on 04 Nov 2026.
Does ALB pay a dividend?
Yes. Albemarle Corporation pays a dividend with a current yield of 1.49%, at an annual rate of $1.64 per share.
View live charts, options flow, gamma exposure, earnings history, and technical analysis for Albemarle Corporation on Apsis Markets.